Sarai Palanca-Suela

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Detection of Circulating Tumour DNA in Plasma during the Treatment of In-transit Melanoma Metastases with Topical Imiquimod.

Detection of Circulating Tumour DNA in Plasma during the Treatment of In-transit Melanoma Metastases with Topical Imiquimod.

Journal: Acta dermato-venereologica

Published: November 26, 2025

Corrigendum to "Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)" [Lung Cancer 206 (2025) 108677].

Corrigendum to "Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)" [Lung Cancer 206 (2025) 108677].

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 09, 2025

Circulating tumor DNA predicts tumor progression and poor survival in patients with stage III melanoma.

Circulating tumor DNA predicts tumor progression and poor survival in patients with stage III melanoma.

Journal: Melanoma research

Published: May 19, 2025

Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study).

Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 06, 2025

Study of Microsatellite Instability by Immunohistochemistry in a Cohort of Patients With Melanoma.

Study of Microsatellite Instability by Immunohistochemistry in a Cohort of Patients With Melanoma.

Journal: Journal of cutaneous pathology

Published: April 01, 2024

MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase.

MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase.

Journal: Genes

Published: November 18, 2021

MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.

MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.

Journal: Melanoma research

Published: November 25, 2020

Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital.

Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital.

Journal: Cancers

Published: July 30, 2019

Telomerase Expression in a Series of Melanocytic Neoplasms.

Telomerase Expression in a Series of Melanocytic Neoplasms.

Journal: Actas dermo-sifiliograficas

Published: April 13, 2018

Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.

Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.

Journal: The British journal of dermatology

Published: December 13, 2017

Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.

Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.

Journal: Scientific reports

Published: October 26, 2016

Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer.

Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer.

Journal: Familial cancer

Published: January 03, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026